Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrey V Sosnov

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 7, 2013
Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: the special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazoleAndrei A Gakh, Andrey V Sosnov, Mikhail Krasavin, et al.
ISRN Oncology|November 16, 2011
Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate CancersNatalia Yu Anisimova, Andrey V Sosnov, Nadezhda E Ustyuzhanina, et al.
Carbohydrate Research|January 16, 2003
Study of 1-deoxy-1-(indol-3-yl)-L-sorbose, 1-deoxy-1-(indol-3-yl)-L-tagatose, and their analogsSergey N Lavrenov, Alexander M Korolev, Marina I Reznikova, et al.
Chemistry Central Journal|December 22, 2011
Trans-, cis-, and dihydro-resveratrol: a comparative studyNatalia Yu Anisimova, Mikhail V Kiselevsky, Andrey V Sosnov, et al.
Chemistry Central Journal|March 11, 2010
Discovery and SAR exploration of N-aryl-N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents for prostate cancerMikhail Krasavin, Konstantin A Rufanov, Andrey V Sosnov, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2014
Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotypeMikhail Krasavin, Andrey V Sosnov, Ruben Karapetian, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2010
Dihydro-resveratrol--a potent dietary polyphenolAndrei A Gakh, Natalia Yu Anisimova, Mikhail V Kiselevsky, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|February 7, 2013
Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: the special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazoleAndrei A Gakh, Andrey V Sosnov, Mikhail Krasavin, et al.
ISRN Oncology|November 16, 2011
Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate CancersNatalia Yu Anisimova, Andrey V Sosnov, Nadezhda E Ustyuzhanina, et al.
Carbohydrate Research|January 16, 2003
Study of 1-deoxy-1-(indol-3-yl)-L-sorbose, 1-deoxy-1-(indol-3-yl)-L-tagatose, and their analogsSergey N Lavrenov, Alexander M Korolev, Marina I Reznikova, et al.
Chemistry Central Journal|December 22, 2011
Trans-, cis-, and dihydro-resveratrol: a comparative studyNatalia Yu Anisimova, Mikhail V Kiselevsky, Andrey V Sosnov, et al.
Chemistry Central Journal|March 11, 2010
Discovery and SAR exploration of N-aryl-N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents for prostate cancerMikhail Krasavin, Konstantin A Rufanov, Andrey V Sosnov, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2014
Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotypeMikhail Krasavin, Andrey V Sosnov, Ruben Karapetian, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2010
Dihydro-resveratrol--a potent dietary polyphenolAndrei A Gakh, Natalia Yu Anisimova, Mikhail V Kiselevsky, et al.
Pageof 1